Location: Home
  • search
  • go
  • Relate News
  • 8/9/2022Analysis of Regulations for Approval of Digital Therapeutics in China
  • 8/8/2022Emerging Biopharma's Contribution to Innovation (IQVIA)
  • 8/8/2022Bayer's Xarelto Squeeze Rolls on As Cancer Newcomer Nubeqa Gains Steam
  • 8/8/2022Hansoh and TiumBio Enter $164M Licensing Pact for TU2670 in China
  • 8/8/2022AstraZeneca and Wuxi Biologics Tie Up to Make Preventive Covid-19 Jab ...
  • 8/8/2022Grand Pharma and XELTIS Enter Strategic Partnership for Endogenous Tis...
  • 8/5/2022CNIPA Rules In Favor of Boehringer in First Important Patent Infringem...
  • 8/5/2022More Than 30 Chinese Health Official Investigated/Prosecuted for Corru...
  • 8/5/2022Recent Executive Moves
  • 8/5/2022Drug R&D and Product Registration News Digest August 2022 (1)
  • 8/5/2022Bird's Eye View of Chinese Pharma Now: A Mixed Bag of Mostly Negative ...
  • 8/4/2022Sanofi Enters Strategic and €300M Investment Pact with Innovent for ...
  • 8/3/2022Review of Chinese New Drug Clinical Trial Applications in H1/2022
  • 8/2/2022CDE Solicits Comments on Draft "Common Pharmacy Issues and Related Tec...
  • 8/2/2022NHC: Chinese Population to Start Declining by 2025
  • 8/2/2022Nippon Express (China) Opens New Healthcare Branch in Shanghai
  • 8/2/2022China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...
  • 8/1/2022Prevalence of Stroke in China, 2013–2019: A Population-based Study
  • 8/1/2022CDE Issues the Q&As on Non-Clinical and Clinical Evaluation Criteria f...
  • 8/1/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 7/29/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines ICH ...
  • 7/29/2022NHC and SATCM Issues Notice to Further Strengthen Drug Safety Manageme...
  • 7/29/2022Recent Official and Executive Moves
  • 7/29/2022Drug R&D and Product Registration News Digest July 2022 (4)
  • 7/29/2022Financial-related Company News in Brief (July 2022)
  • 7/29/2022Drug R&D and Approvals in China – June Update on YouTube (PharmCube)
  • 7/29/2022Pricing and Market Access in China: How Medtechs Can Succeed
  • 7/28/2022June In-Licensing Deals in China Biotech Drop to A New Low (PharmaDJ)
  • 7/28/2022Cosmo and 3SBio Enter License Agreement for Winlevi in Greater China
  • 7/28/2022Elevation Oncology and CSPC Pharma Enter Licensing Deal for Latter's A...
  • Page:131/774 Total number of articles:23207: [First][<<] [129] [130] [131] [132] [133] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group